BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Agrawal AK, Bobiński P, Grzebieniak Z, Rudnicki J, Marek G, Kobielak P, Kazanowski M, Agrawal S, Hałoń A. Pseudomyxoma peritonei originating from urachus-case report and review of the literature. Curr Oncol 2014;21:e155-65. [PMID: 24523614 DOI: 10.3747/co.21.1695] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Chahal D, Martens M, Kinahan J. Mucinous cystic tumour of low malignant potential presenting in a patient with prior non-seminatous germ cell tumour. Can Urol Assoc J 2015;9:E750-3. [PMID: 26664515 DOI: 10.5489/cuaj.2946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Valasek MA, Pai RK. An Update on the Diagnosis, Grading, and Staging of Appendiceal Mucinous Neoplasms. Advances in Anatomic Pathology 2018;25:38-60. [DOI: 10.1097/pap.0000000000000178] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 7.8] [Reference Citation Analysis]
3 Wang LL, Liddell H, Tanny ST, Norris B, Appu S, Pan D. Incidental Finding of a Rare Urachal Pathology: Urachal Mucinous Cystic Tumour of Low Malignant Potential. Case Rep Urol 2016;2016:5764625. [PMID: 26881171 DOI: 10.1155/2016/5764625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Shariff US, Chandrakumaran K, Dayal S, Mohamed F, Cecil TD, Moran BJ. Mode of Presentation in 1070 Patients With Perforated Epithelial Appendiceal Tumors, Predominantly with Pseudomyxoma Peritonei. Dis Colon Rectum 2020;63:1257-64. [PMID: 33216496 DOI: 10.1097/DCR.0000000000001682] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Gong Y, Wang X, Zhu Z. Pseudomyxoma Peritonei Originating from Transverse Colon Mucinous Adenocarcinoma: A Case Report and Literature Review. Gastroenterol Res Pract 2020;2020:5826214. [PMID: 32714388 DOI: 10.1155/2020/5826214] [Reference Citation Analysis]
6 Li X, Liu S, Yao S, Wang M. A Rare Case of Urachal Mucinous Adenocarcinoma Detected by 18F-FDG PET/CT. Clinical Nuclear Medicine 2015;40:282-5. [DOI: 10.1097/rlu.0000000000000674] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Yan F, Shi F, Li X, Yu C, Lin Y, Li Y, Jin M. Clinicopathological Characteristics of Pseudomyxoma Peritonei Originated from Ovaries.Cancer Manag Res. 2020;12:7569-7578. [PMID: 32904568 DOI: 10.2147/CMAR.S264474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Sekulic M, Pichler Sekulic S, Movahedi-Lankarani S. Synchronous Low-grade Appendiceal Mucinous Neoplasm and Primary Peritoneal Low-grade Serous Carcinoma: A First Description of These 2 Neoplasms Presenting Together as Suspected Peritoneal Carcinomatosis. Int J Gynecol Pathol 2017;36:459-65. [PMID: 27684884 DOI: 10.1097/PGP.0000000000000335] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Ponzini F, Kowal L, Ghafoor M, Goldberg A, Chan J, Lamm R, Cannaday SM, Richard SD, Nevler A, Lavu H, Bowne WB, Rosenblum NG. Rare occurrence of pseudomyxoma peritonei (PMP) syndrome arising from a malignant transformed ovarian primary mature cystic teratoma treated by cytoreductive surgery and HIPEC: a case report. World J Surg Oncol 2022;20:78. [PMID: 35272690 DOI: 10.1186/s12957-022-02548-8] [Reference Citation Analysis]
10 Csanyi-bastien M, Blanchard F, Lamy A, Sabourin J. A case of Pseudomyxoma Peritonei of an unexpected origin. Diagn Pathol 2021;16. [DOI: 10.1186/s13000-021-01179-z] [Reference Citation Analysis]
11 Dimopoulos P, Kampantais S, Payne S, Liyanage S. Pseudomyxoma Peritonei Arising From Urachal Mucinous Adenocarcinoma. Urology 2018;111:e3-4. [PMID: 29024737 DOI: 10.1016/j.urology.2017.09.021] [Reference Citation Analysis]
12 Mercier F, Passot G, Villeneuve L, Levine EA, Yonemura Y, Goéré D, Sugarbaker PH, Marolho C, Bartlett DL, Glehen O; BIG-RENAPE Working Group. Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients. Ann Surg Oncol 2018;25:1094-100. [DOI: 10.1245/s10434-017-6299-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kostov S, Kornovski Y, Slavchev S, Ivanova Y, Dzhenkov D, Yordanov A, Slavcheva S. Pseudomyxoma peritonei of appendiceal origin mimicking ovarian cancer - a case report with literature review. Prz Menopauzalny 2021;20:148-53. [PMID: 34703416 DOI: 10.5114/pm.2021.109120] [Reference Citation Analysis]
14 Zhang W, Tan C, Xu M, Wu X. Appendiceal mucinous neoplasm mimics ovarian tumors: Challenges for preoperative and intraoperative diagnosis and clinical implication. Eur J Surg Oncol. 2019;45:2120-2125. [PMID: 31462390 DOI: 10.1016/j.ejso.2019.08.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
15 Wu J, Liu A, Chen A, Zhang P. Urachal borderline mucinous cystadenoma: A rare case report and literature review. Medicine (Baltimore) 2017;96:e8740. [PMID: 29381965 DOI: 10.1097/MD.0000000000008740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Ye S, Zheng S. Comprehensive Understanding and Evolutional Therapeutic Schemes for Pseudomyxoma Peritonei: A Literature Review. Am J Clin Oncol 2022;45:223-31. [PMID: 35446281 DOI: 10.1097/COC.0000000000000911] [Reference Citation Analysis]
17 Sinukumar S, Mehta S, As R, Damodaran D, Ray M, Zaveri S, Kammar P, Bhatt A. Analysis of Clinical Outcomes of Pseudomyxoma Peritonei from Appendicular Origin Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Retrospective Study from INDEPSO. Indian J Surg Oncol 2019;10:65-70. [PMID: 30886496 DOI: 10.1007/s13193-018-00870-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
18 Liu Y, Ishibashi H, Hirano M, Takeshita K, Mizumoto A, Ichinose M, Nishino E, Kashu I, Yamamoto Y, Sugarbaker PH, Yonemura Y. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus. Ann Surg Oncol 2015;22:2799-805. [DOI: 10.1245/s10434-014-4336-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
19 Shelekhova KV, Zhuravlev AS, Krylova DD, Konstantinov AS, Shtan LV, Kheinshtein VA. Pseudomyxoma Peritonei as a First Manifestation of KRAS-Mutated Urachal Mucinous Cystadenocarcinoma of the Bladder: A Case Report. Int J Surg Pathol 2017;25:563-6. [PMID: 28449606 DOI: 10.1177/1066896917707041] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, González-Moreno S, Taflampas P, Chapman S, Moran BJ; Peritoneal Surface Oncology Group International. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process. Am J Surg Pathol 2016;40:14-26. [PMID: 26492181 DOI: 10.1097/PAS.0000000000000535] [Cited by in Crossref: 276] [Cited by in F6Publishing: 99] [Article Influence: 46.0] [Reference Citation Analysis]
21 Carr NJ, Bibeau F, Bradley RF, Dartigues P, Feakins RM, Geisinger KR, Gui X, Isaac S, Milione M, Misdraji J, Pai RK, Rodriguez-Justo M, Sobin LH, van Velthuysen MF, Yantiss RK. The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei. Histopathology. 2017;71:847-858. [PMID: 28746986 DOI: 10.1111/his.13324] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 18.0] [Reference Citation Analysis]
22 Brennan K, Johnson P, Curtis H, Arnason T. Urachal Mucinous Cystic Tumor of Low Malignant Potential with Concurrent Sigmoid Colon Adenocarcinoma. Case Rep Gastrointest Med 2019;2019:1434838. [PMID: 31341685 DOI: 10.1155/2019/1434838] [Reference Citation Analysis]
23 Delhorme JB, Severac F, Averous G, Glehen O, Passot G, Bakrin N, Marchal F, Pocard M, Lo Dico R, Eveno C, Carrere S, Sgarbura O, Quenet F, Ferron G, Goéré D, Brigand C; French National Network of Peritoneal Surface Malignancies (RENAPE). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin. Br J Surg 2018;105:668-76. [PMID: 29412465 DOI: 10.1002/bjs.10716] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
24 García KM, Flores KM, Ruiz A, González FL, Rodríguez ÁM. Pseudomyxoma Peritonei: Case Report and Literature Review. J Gastrointest Cancer 2019;50:1037-42. [PMID: 30618002 DOI: 10.1007/s12029-018-00192-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Narasimhan V, Wilson K, Britto M, Warrier S, Lynch AC, Michael M, Tie J, Akhurst T, Mitchell C, Ramsay R, Heriot A. Outcomes Following Cytoreduction and HIPEC for Pseudomyxoma Peritonei: 10-Year Experience. J Gastrointest Surg 2020;24:899-906. [PMID: 31090036 DOI: 10.1007/s11605-019-04239-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
26 Ramaswamy V. Pathology of mucinous appendiceal tumors and pseudomyxoma peritonei. Indian J Surg Oncol. 2016;7:258-267. [PMID: 27065718 DOI: 10.1007/s13193-016-0516-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]